Canada closes dominance probe of pharma

Canada’s Competition Bureau has ended its investigation into Celgene, Pfizer and Sanofi-Aventis for allegedly denying generic drugmakers the medicine samples they need for regulatory testing to bring competing products to market.


Get unlimited access to all Global Competition Review content